Stockscreener 앱 받기
0.06
4.15%
-0.0026
시장 영업 전:
.06
전일 마감가:
$0.0626
열려 있는:
$0.0601
하루 거래량:
14.17M
Relative Volume:
0.65
시가총액:
$6.69M
수익:
-
순이익/손실:
$-37.28M
주가수익비율:
-0.0769
EPS:
-0.78
순현금흐름:
$-32.24M
1주 성능:
-30.23%
1개월 성능:
-29.66%
6개월 성능:
-94.59%
1년 성능:
-96.10%
1일 변동 폭
$0.0551
$0.0625
1주일 범위
$0.0551
$0.0857
52주 변동 폭
$0.0551
$2.57
Eyenovia Inc Stock (EYEN) Company Profile
명칭
Eyenovia Inc
전화
813-766-9539
주소
295 MADISON AVENUE,, NEW YORK, NY
EYEN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EYEN
Eyenovia Inc
|
0.06 | 6.69M | 0 | -37.28M | -32.24M | -0.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
427.89 | 110.19B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
687.80 | 75.58B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
647.39 | 38.71B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
264.99 | 34.18B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.25 | 28.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Eyenovia Inc Stock (EYEN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-11-18 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-03-01 | 개시 | Northland Capital | Outperform |
| 2020-02-03 | 다운그레이드 | Oppenheimer | Outperform → Perform |
Eyenovia Inc 주식(EYEN)의 최신 뉴스
Financial Survey: Mirum Pharmaceuticals (NASDAQ:MIRM) & Eyenovia (NASDAQ:EYEN) - Defense World
Eyenovia secures $1 million from warrant repricing and exercise - MSN
Eyenovia secures $1 million from warrant repricing and exercise By Investing.com - Investing.com Canada
SEC Form 424B3 filed by Eyenovia Inc. - Quantisnow
Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote 'FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders - The Manila Times
Eyenovia Announces Leading Proxy Advisory Firms, ISS and - GlobeNewswire
Eyenovia Announces Leading Proxy Advisory Firms, ISS and Glass Lewis, Recommend Eyenovia Stockholders Vote “FOR” Proposed Reverse Stock Split at Upcoming Special Meeting of Stockholders - GlobeNewswire Inc.
Ladenburg Thalmann Downgrades Eyenovia (EYEN) - MSN
Geode Capital Management LLC Increases Stock Position in Eyenovia, Inc. (NASDAQ:EYEN) - Defense World
Deal Dispatch: TD Bank To Sell Charles Schwab Stake? Eyenovia, Smart Share Hit Auction Block - Benzinga
Mydriasis Treatment Market 2034: EMA, PDMA, FDA Approval, Clinical Trials, Epidemiology, Therapies and Companies by DelveInsight - The Globe and Mail
Mydriasis Pipeline 2024: Clinical Trials Assessment, FDA Approvals, Therapies, and Key Companies Involved by DelveInsight | Viatris/Ocuphire Pharma, Eyenovia, Rayner Surgical/Omeros, Eyenovia Inc - The Globe and Mail
Eyenovia Eyes Cost-Cutting Measures Amid Disappointing Study Results - MPO-mag
Mydriasis Pipeline 2024: Clinical Trials Assessment, FDA - openPR
Eyenovia explores strategic alternatives, advances Optejet device By Investing.com - Investing.com Nigeria
Eyenovia Hires Financial Adviser Amid Business Review - MarketWatch
Eyenovia Engages Chardan as Advisor for Review of Strategic Alternatives - GlobeNewswire
Eyenovia explores strategic alternatives, advances Optejet device - Investing.com
Eyenovia Explores Strategic Alternatives, Accelerates Optejet Device Development Plans - StockTitan
Eyenovia (NASDAQ:EYEN) Enters into Amended and Restated Sales Agreement with Chardan Capital Markets, LLC - Defense World
Pre-market Movers: ONCO, EYEN, SGMO, VSTM... - RTTNews
SEC Form 424B5 filed by Eyenovia Inc. - Quantisnow
Eyenovia faces Nasdaq delisting over low stock price By Investing.com - Investing.com Nigeria
Eyenovia faces Nasdaq delisting over low stock price - Investing.com
Eyenovia (NASDAQ:EYEN) Announces Completion of Registered Direct Offering - Defense World
Eyenovia’s $1.9M Offering to Boost Optejet Development - TipRanks
Form 424B5 EYENOVIA, INC. - StreetInsider.com
Eyenovia announces pricing of $1.9M registered direct offering - MSN
Eyenovia secures $1.9 million in direct offering By Investing.com - Investing.com Canada
Eyenovia secures $1.9 million in direct offering - Investing.com
Eyenovia, Inc. Announces Pricing of $1.9 Million Registered Direct Offering - GlobeNewswire
Eyenovia Announces $1.9M Direct Offering to Fund Optejet Development, Strategic Growth - StockTitan
These Numbers Show Just How Powerful Eyenovia Inc (NASDAQ: EYEN) Stock Is - Stocks Register
Eyenovia, Inc. (NASDAQ:EYEN) Short Interest Update - Defense World
Eyenovia’s Direct Offering to Support Strategic Initiatives - TipRanks
Eyenovia secures $1.3 million in direct offering By Investing.com - Investing.com South Africa
Eyenovia defers loan payments, issues equity to lenders - Investing.com
Eyenovia defers loan payments, issues equity to lenders By Investing.com - Investing.com Canada
Eyenovia Slumps On Pricing Of Registered Direct Offering - Nasdaq
Eyenovia Restructures Finances and Leadership Team - TipRanks
Eyenovia, Inc. Announces Pricing of $1.3 Million Registered Direct Offering - The Manila Times
Eyenovia secures $1.3 million in direct offering - Investing.com
Eyenovia Raises $1.3M in Direct Offering at $0.1076 Per Share with Warrants | EYEN Stock News - StockTitan
Eyenovia Inc (EYEN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.81%
자본화:
|
볼륨(24시간):